ACS Medicinal Chemistry Letters · 2012 · 28 citations · 17 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationAntibacterial AgentsAntibacterial PharmacologyAntibiotic ResistanceNatural Product Drug DiscoveryNatural Product-based Drug DesignAntibiotic DiscoveryBiological Activity FeaturesNatural Product SynthesisNovel Antibacterial AgentsNovel Antibacterial Drug DiscoveryProduction Of Antimicrobial CompoundsSubstituent Effects On Biological ActivityTuberculosis Drug Development
Dihydropyridomycins 2 and 3, which lack the characteristic enol ester moiety of the potent antimycobacterial natural product pyridomycin (1), have been prepared from l-Thr, R- and S-hydroxy isovaleric acid, and 3-pyridinecarboxaldehyde. The 2R isomer 2 shows only 4-fold lower anti-Mtb activity than 1, indicating that the enol ester moiety in the natural product is not critical for its biological activity. This finding establishes 2 as a potent and more practical lead for anti-TB drug discovery.
17
James A. Dale, David L. Dull, Harry S. Mosher · The Journal of Organic Chemistry · 1969 · 2.5K citations